Journal of Cellular and Molecular Pharmacology

Our Group organises 3000+ Global Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Drug receptor-effective coupling

Receptors are macromolecules complex in actinic signaling and aural cells; they may be amid on the corpuscle apparent film or aural the cytoplasm, Several actinic armament may aftereffect in a acting bounden of the biologic to the receptor. About any band could be complex with the drug-receptor interaction. Covalent bonds would be actual bound and about irreversible. Since by analogue the drug-receptor alternation is reversible, covalent band accumulation is rather attenuate except in a rather baneful situation. Since abounding drugs accommodate acerbic or amine anatomic groups which are ionized at physiological pH, ionic bonds are formed by the allure of adverse accuse in the receptor site. Polar-polar interactions as in hydrogen bonding are a added addendum of the allure of adverse charges. The drug-receptor acknowledgment is about a barter of the hydrogen band amid a biologic molecule, surrounding water, and the receptor site. Finally berserk bonds are formed amid non-polar hydrocarbon groups on the biologic and those in the receptor site. These bonds are not actual specific but the interactions do action to exclude baptize molecules. Repulsive armament which abatement the adherence of the drug-receptor alternation cover abhorrence of like accuse and steric hindrance. Steric albatross refers to assertive 3-dimensional appearance area abhorrence occurs amid electron clouds, adamant actinic bonds, or beefy alkyl groups.

Related Journals: Journal of Receptor and Signal Transduction Research,Journal of Receptor, Ligand and Channel Research , Cardiovascular and Hematological Disorders - Drug Targets , Current Drug Targets , Drug metabolism and pharmacokinetics, Drugs in R and D, Therapeutics, Pharmacology and Clinical Toxicology ,  Acta Pharmacologica Sinica ,Advances in Pharmacology , Journal of Receptor, Ligand and Channel Research ,Biochimica et Biophysica Acta - Biomembranes ,Biochimica et Biophysica Acta - Molecular and Cell Biology of Lipids ,Cell Membranes and Free Radical Research , Current Protein and Peptide Science ,Protein & Cell ,Basic and clinical Pharmacology,Journal of Pharmacokinetics & Experimental Therapeutics

Drug receptor-effective coupling

Expert PPTs

Speaker PPTs

  • Sundeep Kumar Upadhyaya
    LONG TERM DRUG-FREE CLINICAL-REMISSION IN PATIENTS WITH RA ON cDMARDs
    | PDF Version
  • Li Yu-Jung
    Intra-maxillary Drug delivery and Bio-sensing via Dental Implant and its considerations
    | PDF Version
  • Ines Bouaziz
    Water treatment containing organic compounds by coupling adsorption and electrochemical degradation at BDD anode: Sawdust adsorption performance for the treatment of dilute phenol solutions
    | PDF Version
  • Carsten Worsoe
    The value of the “simulated study” as a tool to predict actual leachables in parenteral drug products
    | PDF Version
  • Diane Paskiet
    Qualifi cation of extractables & leachables from container closure systems in drug products- Introduction to the Product Quality Institute (PQRI) recommendations
    | PDF Version
  • Li-Chun Tsou
    Drug delivery device strategy for patient centric therapies
    | PDF Version
  • Neervalur V Raghavan
    Systematic approach to development of aqueous drug formulation and drug device combination injectable products and challenges
    | PDF Version
  • Panayiotis P Constantinides
    Parenteral Drug Nanodispersions : Manufacturing, Characterization and In Vitro/In Vivo Performance Evaluation
    | PDF Version
  • Jan Voskuil
    How antibodies can prevent medical progress and how they can be great tools?
    | PDF Version
  • Arshad mahmood
    TRANSPORT OF SELF-NANOEMULSIFYING DRUG DELIVERY SYSTEM (SNEDDS) ACROSS MUCUS AND CELLULAR INTERNALIZATION
    | PDF Version
  • Hugo Albrecht
    Towards pharmacological validation of MNKs as anti-cancer drug targets
    | PDF Version
  • Vivek Lal
    New drug development in type-2 diabetes mellitus : current and future trends – an overview
    | PDF Version
  • Joan Smith Sonneborn
    Novel anti-retroviral drug targets: Interfering siRNA and mitochondrial TERT expression
    | PDF Version
  • Barbara Klajnert-Maculewicz
    Sugar-modified PPI dendrimers as carriers of anti-leukemia drugs
    | PDF Version
  • Adel Nefzi
    “Adel Nefzi-Torrey-Pines-Institute-for-Molecular-Studies-USA-Diversity-Oriented-Synthesis-of-low-Molecular-Weight-Acyclic-and-Heterocyclic-Compounds-from-Resin-bound-Polyamides-Application-for-Drug-Discovery”
    | PDF Version
  • Tanvir Ahmed
    Sexual partners and condom use attitude: Qualitative findings among injecting drug users in Hai Phong, Vietnam
    | PDF Version
  • Mukesh Kumar
    Membrane fusion mediated cytosolic drug delivery through scFv targeted Sendai viral envelopes
    | PDF Version
  • Thomas J Franz
    Assessing the BA and BE of Topical Dermatologic Drug Products with Multiple Surrogate Methods
    | PDF Version
  • Rinat Islamov
    Pharmacokinetics (PK) of anti-tuberculosis drug (FS-1) on healthy volunteers: results from the phase I trial
    | PDF Version
  • Almas Okassov
    Chemical modification of anticancer Parasporins for decreasing of their toxicity
    | PDF Version
  • Akujobi Comfort
    Multi drug-resistant tuberculosis (MDR-TB) among HIV positive patients in a tertiary institution in south eastern Nigeria
    | PDF Version
  • Sevgi Gungor
    Micelles as nanosized carriers for skin delivery of drugs
    | PDF Version
  • Ru Band Lu
    Anti-Inflammation and neuroprotective drugs benefit the treatment of heroin dependent patients
    | PDF Version
  • Helmi Mardassi
    A ten-year evolution of a multidrug-resistant tuberculosis (MDR-TB) outbreak in an HIV-negative context, Tunisia (2001-2011)
    | PDF Version
  • Sungchul Ji
    Mathematical Models of RNA Expression Profiles: Potential Applications to Drug Discovery Research and Personalized Medicine
    | PDF Version
  • Anita Nair
    BCS-Based Biowaivers: Which Drugs are Eligible?
    | PDF Version
  • Adriana Katz
    Na,K-ATPase isoform-selective cardiac glycosides- a potential anti-cancer drug ?
    | PDF Version
  • Eggehard Holler
    Biodegradable nanobrushes for drug delivery
    | PDF Version
  • Tao Lu
    Using VBIM technique to identify drug resistance genes in ovarian cancer
    | PDF Version
  • Navneet Sharma
    Transdermal patches based on solid lipid nanoparticles of Metformin: Novel approach for drug delivery of Type 2 diabetes
    | PDF Version
  • Viral Kansara
    Ocular melanin modulates pharmacokinetics and drug disposition of therapeutic agents
    | PDF Version
  • Richard A. Kenley
    Equilibrium binding interactions between lotrafilcon a soft contact lenses and the two prostaglandin anti-glaucoma drugs Bimatoprost and Tafluprost
    | PDF Version
  • Elena Gavrilova
    Application of drugs based on release-active antibodies as immunotherapy agents
    | PDF Version
  • William Lee
    Regulatory roadmap for initiating a cell therapy drug into clinical trials in the US
    | PDF Version
  • Krasimira Pekova
    Have FDA expedited programs really shortened drug review time? an analysis of newly approved therapies and how FDA expedited programs have impacted drug development timelines
    | PDF Version
  • Jasmin Kaur
    Helping clinicians connect: Understanding addiction from the perspective of a drug abuser
    | PDF Version
  • Matin Peters
    Cognitive-behavioral therapy as an effective treatment method in the ASEAN setting
    | PDF Version
  • Marcelo Febo
    3,4-Methylenedioxypyrovalerone (MDPV), a major bath salt drug, reduces functional connectivity in rat brain
    | PDF Version
  • Jim Klostergaard
    Magnetic vectoring for drug delivery to tumors: Past, present and is there a future?
    | PDF Version
  • Sree Harsha
    Optimization of particles size for lung specific drug delivery by way of microspheres
    | PDF Version
  • Mauro Comes Franchini
    Gold, silver magnesium and magnetic nanoparticles: Nanomedicine applications in drug delivery
    | PDF Version
  • W Wagner
    Tumor regression by means of magnetic drug targeting
    | PDF Version
  • Jung-Joon Min
    Bacteria-mediated expression of cargo drugs and reporter gene for cancer-specific theranostics
    | PDF Version
  • Maria Paola COSTI
    A proteomic-bioinformatic integrated approach for studying the effect of a peptide drug candidate on ovarian Cancer
    | PDF Version
  • Vladimir Torchilin
    Stimuli-sensitive combination nanopreparations of siRNA and chemotherapeutic drugs to treat multidrug resistant cancer
    | PDF Version
  • Baharudin Ibrahim
    Personalizing drug treatment using pharmacometabonomic approach
    | PDF Version
  • Ruben Artero
    A Drosophila high-throughput drug screening platform identifies inhibitors of misregulated alternative splicing events in myotonic dystrophy
    | PDF Version
  • Vladimir E. Bondarenko
    Mathematical model of β1-adrenergic signaling in mouse ventricular myocytes as an in silico tool for the cardiovascular drug test
    | PDF Version
  • Maria ISAGULIANTS
    DNA vaccination against drug resistance in chronic viral infections, example of HIV-1
    | PDF Version
  • Grace London
    Development of aptamer based HIV-1 entry inhibitor prophylactic drugs
    | PDF Version
  • Aina Westrheim Ravna
    Novel sildenafil analogues: possible drugs for increased sensitivity to chemotherapeutic agents
    | PDF Version
Conference Proceedings